No Data
Trump Eyes Drug Tariffs By Month-End, Semiconductor Levies Could Follow
Citi Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $404
Trump Says 200% Pharma Tariffs Are Coming. Wall Street Shrugs
BofA Securities Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Raises Target Price to $359
New Analyst Forecast: $ALNY Given 'Buy' Rating
Alnylam Pharmaceuticals Is Maintained at Buy by B of A Securities